Prostate
C61WHO Vol. 8
Male Reproductive System
★ 8.0Nature Reviews Clinical Oncology
2026-08-26
Global cancer statistics 2024: translating epidemiological trends into priorities for healthcare systems
A review in Nature Reviews Clinical Oncology discusses the global cancer burden using GLOBOCAN 2024 estimates: in 2024, 20.6 million people across 186 countries were diagnosed with cancer and 9.8 million died of it. Lung cancer remains the most common — 2.6 million new cases (12.8%) and 1.9 million …
Read the full story →★ 8.0The Lancet
2026-08-06
Phase 3 PSMAddition: adding [177Lu]Lu-PSMA-617 to hormone therapy extends radiographic progression-free survival in PSMA-positive metastatic prostate cancer (HR 0.72)
In the phase 3 PSMAddition trial (1144 patients, 572 per arm), adding the radioligand [177Lu]Lu-PSMA-617 to androgen deprivation therapy plus an androgen-receptor pathway inhibitor prolonged radiographic progression-free survival: HR 0.72 (95% CI 0.58-0.90; p=0.0021), a 28% relative reduction in the…
Read the full story →